| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
65,050 |
58,667 |
$23.22M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
15,598 |
14,122 |
$4.64M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,940 |
11,401 |
$3.01M |
| G0378 |
Hospital observation service, per hour |
6,633 |
5,106 |
$2.56M |
| 59025 |
Fetal non-stress test |
4,263 |
1,494 |
$2.34M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,321 |
6,047 |
$1.07M |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,357 |
838 |
$1.04M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,231 |
4,018 |
$968K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
4,641 |
4,292 |
$769K |
| 70450 |
Computed tomography, head or brain; without contrast material |
7,168 |
6,520 |
$593K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
1,830 |
1,793 |
$572K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
17,624 |
13,554 |
$529K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
18,133 |
15,947 |
$496K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
13,040 |
9,414 |
$443K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
16,513 |
3,715 |
$424K |
| OP370 |
|
4,523 |
4,074 |
$409K |
| 76801 |
|
2,989 |
2,718 |
$403K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
7,680 |
4,705 |
$359K |
| OP710 |
|
6,697 |
5,432 |
$301K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,724 |
5,400 |
$296K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
2,987 |
1,432 |
$290K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,977 |
1,854 |
$273K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,423 |
1,392 |
$254K |
| 95806 |
|
289 |
281 |
$246K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
46,568 |
36,487 |
$226K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
880 |
822 |
$220K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,863 |
1,702 |
$205K |
| 93975 |
|
2,693 |
2,524 |
$199K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
1,998 |
1,904 |
$183K |
| 71046 |
Radiologic examination, chest; 2 views |
8,057 |
7,663 |
$178K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,999 |
1,922 |
$177K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,879 |
1,394 |
$174K |
| OP259 |
|
79,979 |
37,080 |
$174K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
11,063 |
10,165 |
$169K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,507 |
3,260 |
$160K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
35,084 |
29,405 |
$154K |
| 71045 |
Radiologic examination, chest; single view |
12,599 |
11,377 |
$152K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
771 |
381 |
$150K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
4,350 |
4,077 |
$131K |
| 76830 |
Ultrasound, transvaginal |
1,509 |
1,459 |
$127K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
10,791 |
9,881 |
$127K |
| 76813 |
|
849 |
831 |
$126K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
4,439 |
1,185 |
$126K |
| 93017 |
|
255 |
244 |
$115K |
| 80053 |
Comprehensive metabolic panel |
12,240 |
9,576 |
$111K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,373 |
4,640 |
$108K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,316 |
1,158 |
$102K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
2,794 |
724 |
$102K |
| OP250 |
|
54,435 |
37,731 |
$99K |
| 93971 |
|
894 |
849 |
$97K |
| OP272 |
|
14,082 |
9,402 |
$94K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
68 |
61 |
$88K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
894 |
779 |
$75K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,541 |
1,521 |
$71K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
717 |
713 |
$68K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,502 |
1,114 |
$67K |
| 96376 |
|
4,283 |
2,499 |
$65K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
478 |
422 |
$61K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,938 |
7,620 |
$58K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
971 |
916 |
$58K |
| 84484 |
|
10,669 |
7,942 |
$57K |
| 73562 |
|
2,264 |
2,046 |
$55K |
| 93970 |
|
387 |
346 |
$54K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,932 |
1,703 |
$53K |
| 73630 |
|
2,112 |
1,948 |
$52K |
| 97162 |
|
1,314 |
1,164 |
$50K |
| 73610 |
|
2,067 |
1,945 |
$48K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,301 |
2,057 |
$47K |
| 74018 |
|
2,617 |
2,496 |
$47K |
| 96367 |
|
1,300 |
790 |
$46K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
137 |
133 |
$43K |
| 72100 |
|
2,004 |
1,858 |
$42K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
31 |
31 |
$40K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,058 |
2,758 |
$40K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
855 |
780 |
$40K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
282 |
256 |
$38K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
310 |
274 |
$38K |
| 74022 |
|
1,277 |
1,224 |
$35K |
| 73130 |
|
1,480 |
1,370 |
$33K |
| 97161 |
|
1,023 |
884 |
$32K |
| 73030 |
|
1,607 |
1,463 |
$32K |
| 81025 |
|
18,444 |
16,810 |
$32K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,400 |
1,335 |
$31K |
| 36415 |
Collection of venous blood by venipuncture |
11,100 |
9,462 |
$30K |
| 80076 |
|
9,815 |
8,749 |
$28K |
| 85610 |
|
11,671 |
10,348 |
$27K |
| OP271 |
|
6,369 |
5,147 |
$27K |
| OP258 |
|
13,220 |
7,971 |
$26K |
| 85027 |
|
5,840 |
5,027 |
$26K |
| 70496 |
|
203 |
181 |
$24K |
| 73110 |
|
1,002 |
932 |
$23K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,928 |
1,838 |
$22K |
| 87088 |
|
7,786 |
7,123 |
$22K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
5,358 |
3,569 |
$22K |
| 85730 |
|
9,526 |
8,562 |
$22K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,912 |
1,822 |
$21K |
| 83690 |
|
10,074 |
9,093 |
$21K |
| 95800 |
|
68 |
67 |
$21K |
| 86850 |
|
3,795 |
3,414 |
$21K |
| 81003 |
|
17,034 |
15,596 |
$20K |
| 87070 |
|
5,089 |
4,879 |
$19K |
| 87040 |
|
3,482 |
3,110 |
$19K |
| J3490 |
Unclassified drugs |
3,254 |
2,467 |
$19K |
| 52000 |
|
36 |
31 |
$19K |
| 81001 |
|
13,231 |
12,081 |
$19K |
| 83735 |
|
7,461 |
5,617 |
$18K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,332 |
2,822 |
$18K |
| 82948 |
|
8,052 |
4,753 |
$18K |
| 76818 |
|
137 |
105 |
$18K |
| 70498 |
|
164 |
142 |
$17K |
| 51741 |
|
16 |
12 |
$17K |
| J1644 |
Injection, heparin sodium, per 1000 units |
4,078 |
1,780 |
$17K |
| 94760 |
|
1,550 |
880 |
$17K |
| C1776 |
Joint device (implantable) |
37 |
26 |
$17K |
| 88304 |
|
1,006 |
876 |
$17K |
| 80061 |
Lipid panel |
2,116 |
1,982 |
$17K |
| 72040 |
|
909 |
831 |
$17K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,927 |
1,233 |
$16K |
| J2704 |
Injection, propofol, 10 mg |
4,880 |
4,250 |
$16K |
| A9270 |
Non-covered item or service |
2,035 |
1,505 |
$16K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
15,316 |
12,475 |
$15K |
| 71250 |
|
191 |
171 |
$15K |
| J2785 |
Injection, regadenoson, 0.1 mg |
93 |
89 |
$15K |
| 83880 |
|
1,585 |
1,383 |
$14K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,782 |
1,692 |
$14K |
| 87581 |
|
1,042 |
990 |
$14K |
| 87186 |
|
2,429 |
2,203 |
$14K |
| 87641 |
|
370 |
333 |
$14K |
| J1815 |
Injection, insulin, per 5 units |
1,386 |
723 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,705 |
3,629 |
$14K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
107 |
103 |
$14K |
| 76642 |
|
134 |
134 |
$13K |
| 70486 |
|
129 |
115 |
$12K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,642 |
1,542 |
$12K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,855 |
3,822 |
$12K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,845 |
2,569 |
$12K |
| 84702 |
|
2,160 |
1,891 |
$11K |
| 86900 |
|
3,785 |
3,416 |
$11K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
9,982 |
8,396 |
$11K |
| 73080 |
|
461 |
418 |
$10K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
16,221 |
13,561 |
$10K |
| 73502 |
|
336 |
310 |
$10K |
| 87077 |
|
2,577 |
2,332 |
$10K |
| 87486 |
|
1,040 |
988 |
$10K |
| 86901 |
|
3,813 |
3,431 |
$9K |
| 36591 |
|
486 |
273 |
$9K |
| 87147 |
|
2,576 |
2,447 |
$9K |
| 84145 |
|
1,303 |
1,178 |
$8K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
5,996 |
4,365 |
$8K |
| 84439 |
|
1,528 |
1,413 |
$8K |
| 87081 |
|
723 |
647 |
$8K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
5,175 |
3,433 |
$7K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
4,653 |
3,610 |
$6K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,769 |
2,076 |
$6K |
| 85379 |
|
2,519 |
2,384 |
$6K |
| 87807 |
|
1,375 |
1,343 |
$6K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,863 |
3,169 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
377 |
324 |
$6K |
| 80047 |
|
1,470 |
1,384 |
$6K |
| 10060 |
|
75 |
66 |
$6K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
55 |
55 |
$5K |
| 82728 |
|
657 |
566 |
$5K |
| 77066 |
Tomosynthesis, mammo |
41 |
41 |
$5K |
| 29515 |
|
121 |
116 |
$5K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
448 |
444 |
$5K |
| 86140 |
|
2,617 |
2,393 |
$5K |
| 87205 |
|
1,489 |
1,356 |
$4K |
| 29125 |
|
141 |
128 |
$4K |
| 82150 |
|
2,270 |
2,118 |
$4K |
| 82607 |
|
619 |
535 |
$4K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
4,855 |
2,937 |
$4K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
29 |
26 |
$4K |
| 85652 |
|
1,501 |
1,333 |
$4K |
| 73140 |
|
219 |
203 |
$4K |
| 90715 |
|
587 |
529 |
$4K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,095 |
886 |
$3K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,421 |
568 |
$3K |
| 83605 |
|
296 |
274 |
$3K |
| 83615 |
|
1,738 |
1,552 |
$3K |
| J2060 |
Injection, lorazepam, 2 mg |
2,273 |
1,753 |
$3K |
| 83550 |
|
985 |
859 |
$3K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,064 |
764 |
$3K |
| 82746 |
|
421 |
362 |
$3K |
| 83540 |
|
1,029 |
898 |
$3K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
772 |
631 |
$3K |
| C9113 |
Injection, pantoprazole sodium, per vial |
1,063 |
576 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
138 |
124 |
$2K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
911 |
507 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
45 |
40 |
$2K |
| 82247 |
|
336 |
241 |
$2K |
| 12001 |
|
104 |
91 |
$2K |
| 76870 |
|
14 |
13 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
55 |
41 |
$2K |
| 94664 |
|
537 |
520 |
$2K |
| 71101 |
|
40 |
38 |
$2K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,699 |
2,133 |
$2K |
| 73590 |
|
65 |
58 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
73 |
72 |
$1K |
| 82378 |
|
27 |
25 |
$1K |
| 70460 |
|
37 |
33 |
$1K |
| 82248 |
|
150 |
117 |
$1K |
| 82977 |
|
167 |
146 |
$1K |
| 85014 |
|
1,173 |
1,109 |
$1K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
33 |
19 |
$1K |
| 73090 |
|
73 |
67 |
$1K |
| 97165 |
|
28 |
25 |
$1K |
| 85018 |
|
1,170 |
1,106 |
$1K |
| 72072 |
|
36 |
36 |
$973.64 |
| 82550 |
|
419 |
341 |
$896.19 |
| L1831 |
Knee orthosis, locking knee joint(s), positional orthosis, prefabricated, includes fitting and adjustment |
52 |
52 |
$891.18 |
| M0244 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency |
12 |
12 |
$882.20 |
| 82805 |
|
94 |
78 |
$857.65 |
| OP270 |
|
469 |
285 |
$814.17 |
| 76770 |
|
12 |
12 |
$794.74 |
| 81002 |
|
460 |
180 |
$768.08 |
| 86308 |
|
243 |
239 |
$717.35 |
| 87075 |
|
26 |
24 |
$717.05 |
| 76820 |
|
23 |
12 |
$657.02 |
| 88311 |
|
154 |
122 |
$607.05 |
| 97022 |
|
238 |
65 |
$590.57 |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
20 |
16 |
$554.95 |
| J3480 |
Injection, potassium chloride, per 2 meq |
225 |
145 |
$531.83 |
| J3411 |
Injection, thiamine hcl, 100 mg |
73 |
61 |
$514.59 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
474 |
299 |
$478.58 |
| 84132 |
|
458 |
379 |
$476.02 |
| 82570 |
|
305 |
248 |
$474.17 |
| 0003A |
|
15 |
14 |
$460.24 |
| 96368 |
|
51 |
26 |
$427.89 |
| 84100 |
|
660 |
428 |
$423.14 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
283 |
238 |
$411.17 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
238 |
164 |
$396.72 |
| 12011 |
|
41 |
37 |
$348.99 |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
21 |
14 |
$323.02 |
| 86618 |
|
56 |
50 |
$311.36 |
| J3360 |
Injection, diazepam, up to 5 mg |
78 |
64 |
$261.44 |
| 87046 |
|
80 |
67 |
$254.04 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
186 |
79 |
$252.70 |
| 12002 |
|
14 |
12 |
$233.61 |
| 86803 |
|
12 |
12 |
$227.13 |
| 84550 |
|
138 |
108 |
$225.30 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
110 |
68 |
$194.04 |
| 87899 |
|
73 |
66 |
$186.92 |
| 87427 |
|
71 |
64 |
$164.77 |
| 87471 |
|
14 |
14 |
$148.20 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
104 |
65 |
$147.82 |
| 87181 |
|
82 |
82 |
$145.23 |
| 36416 |
|
62 |
49 |
$140.89 |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
616 |
317 |
$138.34 |
| 87045 |
|
74 |
67 |
$137.51 |
| J1630 |
Injection, haloperidol, up to 5 mg |
167 |
134 |
$97.73 |
| 87328 |
|
12 |
12 |
$72.85 |
| 87329 |
|
12 |
12 |
$70.83 |
| A4217 |
Sterile water/saline, 500 ml |
258 |
250 |
$63.53 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
239 |
114 |
$55.26 |
| 84156 |
|
41 |
27 |
$43.23 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
12 |
12 |
$41.34 |
| G0008 |
Administration of influenza virus vaccine |
28 |
27 |
$39.00 |
| 85045 |
|
16 |
13 |
$38.52 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
170 |
100 |
$35.88 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
124 |
88 |
$32.30 |
| 87493 |
|
13 |
12 |
$32.02 |
| 90686 |
|
16 |
15 |
$31.34 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
14 |
12 |
$30.22 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
32 |
15 |
$29.80 |
| 86592 |
|
26 |
26 |
$23.99 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
157 |
111 |
$12.45 |
| Q0247 |
Injection, sotrovimab, 500 mg |
13 |
12 |
$12.26 |
| Q0222 |
Injection, bebtelovimab, 175 mg |
20 |
15 |
$2.36 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
12 |
12 |
$2.32 |
| 91300 |
|
15 |
14 |
$2.00 |
| 76937 |
|
17 |
13 |
$0.00 |